what is gray tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly TAVR-MET: Early Signs Point to

Semaglutide: The Pharmaceutical Powerhouse Semaglutide is a GLP-1 receptor agonist initially developed for type 2 diabetes and now widely used for weight loss and metabolic support

Individual healthcare providers often recommend delaying semaglutide initiation until after breastfeeding ends or weaning is substantially complete

None of that says what would happen if some smaller dose had been used in a clinical trial, such as 1mg of tirzepatide (40% of its standard starting dose and 6.7% of the full dose) or 0.1mg of semaglutide (40% of its standard starting dose and 4.2% of the full dose)

The main mechanism of drug induced liver injury is due to the toxicity of the drug itself and the immune reaction, most of the drugs are transformed by hepatocytes, and normal medication will not cause liver injury, but after overdose, a large number of drugs are transformed into water-soluble metabolites by hepatocytes, and the generation of these substances will greatly consume the glutathione in the hepatocytes, resulting in hepatocellular necrosis, and the exogenous glutathione can reduce the toxicity of the drug and the immune reaction, which will cause the liver cell necrosis